Related Experiment Videos
Peroxisomal beta-oxidation defect with detectable peroxisomes: a case with neonatal onset and progressive course
P G Barth1, R J Wanders, R B Schutgens
1Division of Paediatric Neurology, University Hospital Amsterdam, The Netherlands.
European Journal of Pediatrics
|July 1, 1990
Summary
This study describes a rare demyelinating brain disorder in an infant caused by impaired peroxisomal beta-oxidation. The findings point to a specific enzyme deficiency, aiding in diagnosing this severe neurological condition.
Area of Science:
- Biochemistry
- Neuroscience
- Genetics
Background:
- Peroxisomal disorders are a group of genetic diseases affecting peroxisome function.
- Zellweger syndrome (ZS) is a severe peroxisomal disorder characterized by a wide range of clinical manifestations.
Observation:
- A female infant presented with neonatal seizures, psychomotor deterioration, deafness, retinopathy, and peripheral neuropathy.
- Magnetic resonance imaging (MRI) revealed progressive demyelination and absence of neocortical dysplasia, differentiating it from typical Zellweger syndrome.
Findings:
- Biochemical analyses identified impaired peroxisomal beta-oxidation, leading to elevated very long-chain fatty acids (VLCFAs) and bile acid intermediates.
- Immunoblotting showed normal protein levels for key beta-oxidation enzymes, suggesting a deficiency in bifunctional protein or thiolase activity.
Implications:
- This case highlights a distinct peroxisomal disorder caused by a specific enzyme defect in beta-oxidation.
- The findings contribute to understanding the biochemical basis of demyelinating disorders and refining diagnostic criteria for peroxisomal diseases.